This letter to the editor describes the case of a patient with mediastinal germ cell tumor who developed COVID-19 at the end of the first cycle of chemotherapy and continues the discussion on whether it is best to continue or delay administration of chemotherapy with an active COVID-19 infection.
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
Titolo: | Metastatic Mediastinal Germ-Cell Tumor and Concurrent COVID-19: When Chemotherapy Is Not Deferrable | |
Autori: | ||
Data di pubblicazione: | 2021 | |
Rivista: | ||
Abstract: | This letter to the editor describes the case of a patient with mediastinal germ cell tumor who developed COVID-19 at the end of the first cycle of chemotherapy and continues the discussion on whether it is best to continue or delay administration of chemotherapy with an active COVID-19 infection. | |
Handle: | http://hdl.handle.net/11571/1393934 | |
Appare nelle tipologie: | 1.2 Recensione in rivista |
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.